Site Experience and Outcomes in the Trevo Acute Ischemic Stroke (TRACK) Multicenter Registry.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
09 2019
Historique:
pubmed: 19 7 2019
medline: 13 3 2020
entrez: 19 7 2019
Statut: ppublish

Résumé

Background and Purpose- It remains unclear how experience influences outcomes after the advent of stent retriever technology. We studied the relationship between site experience and outcomes in the Trevo Acute Ischemic Stroke multicenter registry. Methods- The 24 sites that enrolled patients in the Trevo Acute Ischemic Stroke registry were trichotomized into low-volume (<2 cases/month), medium-volume (2-4 cases/month), and high-volume centers (>4 cases/month). Baseline features, imaging, and clinical outcomes were compared across the 3 volume strata. A multivariable analysis was performed to assess whether outcomes were influenced by site volumes. Results- A total of 624 patients were included and distributed as low- (n=188 patients, 30.1%), medium- (n=175, 28.1%), and high-volume (n=261, 41.8%) centers. There were no significant differences in terms of age (mean, 66±16 versus 67±14 versus 65±15; P=0.2), baseline National Institutes of Health Stroke Scale (mean, 17.6±6.5 versus 16.8±6.5 versus 17.6±6.9; P=0.43), or occlusion site across the 3 groups. Median (interquartile range) times from stroke onset to groin puncture were 266 (181.8-442.5), 239 (175-389), and 336.5 (221.3-466.5) minutes in low-, medium-, and high-volume centers, respectively (P=0.004). Higher efficiency and better outcomes were seen in higher volume sites as demonstrated by shorter procedural times (median, 97 versus 67 versus 69 minutes; P<0.001), higher balloon guide catheter use (40% versus 36% versus 59%; P≤0.0001), and higher rates of good outcome (90-day modified Rankin Scale [mRS], ≤2; 39% versus 50% versus 53.4%; P=0.02). There were no appreciable differences in symptomatic intracranial hemorrhage or 90-day mortality. After adjustments in the multivariable analysis, there were significantly higher chances of achieving a good outcome in high- versus low-volume (odds ratio, 1.67; 95% CI, 1.03-2.7; P=0.04) and medium- versus low-volume (odds ratio, 1.75; 95% CI, 1.1-2.9; P=0.03) centers, but there were no significant differences between high- and medium-volume centers (P=0.86). Conclusions- Stroke center volumes significantly influence efficiency and outcomes in mechanical thrombectomy.

Identifiants

pubmed: 31318624
doi: 10.1161/STROKEAHA.118.024639
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2455-2460

Auteurs

Raul G Nogueira (RG)

From the Department of Neurology, Emory University School of Medicine, Atlanta, GA (R.G.N., D.C.H., L.C.R., M.R.F.).

Diogo C Haussen (DC)

From the Department of Neurology, Emory University School of Medicine, Atlanta, GA (R.G.N., D.C.H., L.C.R., M.R.F.).

Alicia Castonguay (A)

Department of Neurology, University of Toledo, OH (A.C.).

Leticia C Rebello (LC)

From the Department of Neurology, Emory University School of Medicine, Atlanta, GA (R.G.N., D.C.H., L.C.R., M.R.F.).

Michael Abraham (M)

Department of Neurology, University of Kansas Medical Center, University of Massachusetts Medical School, Worcester (M.A.).

Ajit Puri (A)

Department of Neurosurgery, University of Massachusetts Medical School, Worcester (A.P.).
Department of Radiology, University of Massachusetts Medical School, Worcester (A.P.).

Amer Alshekhlee (A)

Department of Neurology, SSM Neuroscience Institutes, DePaul Health, Bridgeton, MO (A.A.).

Aniel Majjhoo (A)

Department of Neurology, McLaren Flint Neuroscience Institute, Flint, MI (A.M.).
Department of Neurology, McLaren Flint Neuroscience Institute, Flint, MI (A.M.).

Hamed Farid (H)

Neurointerventional Radiology, St. Jude Medical Center, Chicago, IL (H.F.).

Ira Finch (I)

Department of Interventional Radiology, John Muir Medical Center, Walnut Creek, CA (I.F.).

Joey English (J)

Department of Neurology, California Pacific Medical Center, San Francisco (J.E.).

Maxim Mokin (M)

Department of Neurosurgery and Brain Repair, University of South Florida, Tampa (M.M.).

Michael T Froehler (MT)

Cerebrovascular Program, Neurosurgery, Radiology, Vanderbilt University Medical Center, Nashville, TN (M.T.F.).

Mo Kabbani (M)

Department of Neurointervention, Gundersen Lutheran Medical Foundation, Inc, La Crosse, WI (M.K.).

Muhammad A Taqi (MA)

Department of Neurology, Desert Regional Medical Center, Palm Springs, CA (M.A.T.).

Nirav Vora (N)

Department of Neuroradiology, Riverside Radiology, Columbus, OH (N.V., R.B.).

Ramy El Khoury (RE)

Department of Neurology, Tulane University School of Medicine, New Orleans, LA (R.E.K.).

Randall C Edgell (RC)

Department of Surgery, Saint Louis University Hospital, St. Louis, MO (R.C.E.).
Department of Neurology, Saint Louis University Hospital, St. Louis, MO (R.C.E.).

Roberta Novakovic (R)

Department of Radiology, University of Texas Southwestern, Dallas (R.N.).
Department of Neurology, University of Texas Southwestern, Dallas (R.N.).

Thanh Nguyen (T)

Department of and Neurotherapeutics, University of Texas Southwestern, Dallas (R.N.).
Department of Neurology, Boston Medical Center, MA (T.N.).
Department of Neurosurgery, Boston Medical Center, MA (T.N.).

Vallabh Janardhan (V)

Department of Radiology, Boston Medical Center, MA (T.N.).

Enrol Veznedaroglu (E)

Department of Neurology, Texas Stroke Institute, Plano (V.J.).

Shyam Prabhakaran (S)

Department of Neurosurgery, Drexel Neurosciences Institute, Philadelphia, PA (E.V.).

Ron Budzik (R)

Department of Neuroradiology, Riverside Radiology, Columbus, OH (N.V., R.B.).

Michael R Frankel (MR)

From the Department of Neurology, Emory University School of Medicine, Atlanta, GA (R.G.N., D.C.H., L.C.R., M.R.F.).

Brittany L Nordhaus (BL)

Department of Neurology, Northwestern University, Chicago, IL (S.P.).

Osama O Zaidat (OO)

Department of Neurosciences, Mercy Health-St. Vincent Medical Center, Toledo, OH (B.L.N., O.O.Z.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH